Proteomic and genomic analysis of PITX2 interacting and regulating networks

FEBS Letters

Volumn 583, Issue 4, 2009, Pages 638-642

  Huang, Yue ^a   Huang, Kan ^a   Boskovic, Goran ^a   Dementieva, Yulia ^a   Denvir, James ^b   Primerano, Donald A ^a   Zhu, Guo Zhang ^a  

^a MARSHALL UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Catenin; Differentiation; Pituitary homeobox 2; Proliferation; Y box binding factor 1

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; NUCLEOLIN; TRANSCRIPTION FACTOR PITX2; Y BOX BINDING PROTEIN 1;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATOR GENE; TRANSCRIPTION REGULATION;

BINDING SITES; CELL LINE; GENE EXPRESSION REGULATION; GENOMICS; HOMEODOMAIN PROTEINS; HUMANS; KIDNEY; PROTEIN BINDING; PROTEOMICS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 59849116452     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.01.028     Document Type: Article

References (29)

1. Ai D., Wang J., Amen M., Lu M.-F., Amendt B.A., and Martin J.F. Nuclear factor 1 and T-cell factor/LEF recognition elements regulate PITX2 transcription in pituitary development. Mol. Cell. Biol. 27 (2007) 5765-5775
2. Hayashi M., Maeda S., Aburatani H., Kitamura K., Miyoshi H., Miyazono K., and Imamura T. PITX2 prevents osteoblastic transdifferentiation of myoblasts by bone morphogenetic proteins. J. Biol. Chem. 283 (2008) 565-571
3. Kioussi C., et al. Identification of a Wnt/Dvl/[beta]-catenin → PITX2 pathway mediating cell-type-specific proliferation during development. Cell 111 (2002) 673-685
4. Lin C.R., Kioussi C., O'Connell S., Briata P., Szeto D., Liu F., Izpisua-Belmonte J.C., and Rosenfeld M.G. PITX2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 401 (1999) 279-282
5. Yoshioka H., et al. Pitx2, a bicoid-type homeobox gene, is involved in a lefty-signaling pathway in determination of left-right asymmetry. Cell 94 (1998) 299-305
6. Espinoza H.M., Cox C.J., Semina E.V., and Amendt B.A. A molecular basis for differential developmental anomalies in Axenfeld-Rieger syndrome. Hum. Mol. Genet. 11 (2002) 743-753
7. Semina E.V., et al. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat. Genet. 14 (1996) 392-399
8. Amen M., Liu X., Vadlamudi U., Elizondo G., Diamond E., Engelhardt J.F., and Amendt B.A. PITX2 and {beta}-catenin interactions regulate LEF-1 Isoform Expression. Mol. Cell. Biol. 27 (2007) 7560-7573
9. Vadlamudi U., Espinoza H.M., Ganga M., Martin D.M., Liu X., Engelhardt J.F., and Amendt B.A. PITX2, {beta}-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter. J. Cell Sci. 118 (2005) 1129-1137
10. Toro R., Saadi I., Kuburas A., Nemer M., and Russo A.F. Cell-specific Activation of the Atrial Natriuretic Factor Promoter by PITX2 and MEF2A. J. Biol. Chem. 279 (2004) 52087-52094
11. Amen M., et al. Chromatin-associated HMG-17 is a major regulator of homeodomain transcription factor activity modulated by Wnt/{beta}-catenin signaling. J. Biol. Chem. 36 (2008) 462-476
12. Amendt B.A., Sutherland L.B., and Russo A.F. Multifunctional role of the PITX2 homeodomain protein C-terminal tail. Mol. Cell. Biol. 19 (1999) 7001-7010
13. Schubert S.W., Kardash E., Khan M.A., Cheusova T., Kilian K., Wegner M., and Hashemolhosseini S. Interaction, cooperative promoter modulation, and renal colocalization of GCMa and PITX2. J. Biol. Chem. 279 (2004) 50358-50365
14. Syed H.A.T.D.W. Enhanced oligonucleotide microarray labeling and hybridization. Biotechniques 41 (2006) 685-686
15. Saeed AI S.V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., and Quackenbush J. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 (2003) 374-378
16. Tusher V.T.R., and Chu G. Significance Analysis of Microarrays applied to transcriptional responses to ionizing radiation. Proc. Natl. Acad. Sci. USA 98 (2001) 5116-5121
17. Jurchott K., et al. YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression. J. Biol. Chem. 278 (2003) 27988-27996
18. Mongelard F., and Bouvet P. Nucleolin: a multiFACeTed protein. Trends Cell Biol. 17 (2007) 80-86
19. Moumen A., Masterson P., O'Connor M.J., and Jackson S.P. HnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Cell 123 (2005) 1065-1078
20. Howell M., Borchers C., and Milgram S.L. Heterogeneous nuclear ribonuclear protein U associates with YAP and regulates its co-activation of Bax transcription. J. Biol. Chem. 279 (2004) 26300-26306
21. Birgit Schittek K.P., Sauer B., Meier F., Iftner T., and Garbe C. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance. Int. J. Cancer 120 (2007) 2110-2118
22. Stratford A., et al. Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy. Breast Cancer Res. 9 (2007) R61
23. Chen C.-Y., Gherzi R., Andersen J.S., Gaietta G., Jurchott K., Royer H.-D., Mann M., and Karin M. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev. 14 (2000) 1236-1248
24. Skalweit A., Doller A., Huth A., Kahne T., Persson P.B., and Thiele B.-J. Posttranscriptional control of renin synthesis: identification of proteins interacting with Renin mRNA 3′-untranslated region. Circ. Res. 92 (2003) 419-427
25. Briata P., Ilengo C., Corte G., Moroni C., Rosenfeld M.G., Chen C.-Y., and Gherzi R. The Wnt/[beta]-catenin→PITX2 pathway controls the turnover of PITX2 and other unstable mRNAs. Mol. Cell 12 (2003) 1201-1211
26. Hjalt T.A., Amendt B.A., and Murray J.C. PITX2 regulates procollagen lysyl hydroxylase (PLOD) gene expression: implications for the pathology of Rieger syndrome. J. Cell Biol. 152 (2001) 545-552
27. Baek S.H., et al. Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway. Proc. Natl. Acad. Sci. USA 100 (2003) 3245-3250
28. Venugopalan, S.R. et al. (2008) Novel expression and transcriptional regulation of FoxJ1 during oro-facial morphogenesis. Hum. Mol. Genet., ddn258.
29. Gage P.J., Qian M., Wu D., and Rosenberg K.I. The canonical Wnt signaling antagonist DKK2 is an essential effector of PITX2 function during normal eye development. Dev. Biol. 317 (2008) 310-324